The Long Run with Luke Timmerman
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
Dienstag, 25. April 2023 · 1 h 16
Kapitelklicken springt direkt hin
Shownotes
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.
